[opensourcepharma] Recent OSP items

[Matthew Todd]

Hi all,

A collection of recent items that may be of interest.

1. New GPCR consortium launched along the lines of the SGC:

http://www.fiercebiotech.com/press-releases/new-international-gpcr-consortium-formed-pharma-and-academia-advance-struct?utm_medium=nl&utm_source=internal

(of interest to Peter Kolb and the GLISTEN network in the EU)

2. Discussion on "In the Pipeline" of the cancer crowdfunding campaign and
related issues such as patents:

http://pipeline.corante.com/archives/2014/10/28/an_opensource_cancer_pitch_deconstructed.php

3. Canadian government making major noises about the importance of open
science

http://open.canada.ca/en/content/canadas-action-plan-open-government-2014-16#ch4-3

4. Interesting-looking new call from the Gates Foundation

http://gcgh.grandchallenges.org/GrantOpportunities/Pages/NewInterventions.aspx

5. A number of review articles on drug discovery consortia were published
in the latest issue of Nat Rev Drug Disc

http://www.nature.com/nrd/journal/v13/n11/index.html

6. Time article on Margaret Chan's comments on Ebola and profit incentives

http://time.com/3555706/who-ebola-vaccine-pharmaceutical-industry-margaret-chan/

and an article on Ebola from Piero Olliaro and Els Torreele

http://www.aljazeera.com/indepth/opinion/2014/11/ebola-west-africa-wake-up-call-2014112125429230915.html

7. Platform for crowd investments in health companies (nothing open, I
suspect, but...) - Bernard's an advisor

http://www.poliwogg.com/news/129-path-opens-for-physicians-to-invest-in-healthcare-startups-3

8) There was various coverage of a remark at a New York conference (
http://www.ifpmaassembly2014.org/About-this-event I believe) where the
incoming head of the International Federation of Pharmaceutical
Manufacturer's Association said "There is zero evidence that intellectual
property is a hindrance to access to medicines"

http://blogs.wsj.com/pharmalot/2014/11/12/pharma-trade-group-head-causes-a-stir-with-a-remark-about-patents/

http://www.ip-watch.org/2014/11/07/expect-strong-ip-push-from-global-pharma-industry-next-year-who-prescribes-dose-of-reality/

9) Substantial call for proposals by IMI based on ebola vaccines

http://www.imi.europa.eu/content/ebola-programme-launch

and the IMI is considering a call for proposals in the area of "Knowledge
Repository to enable patient focused medicine development"

http://www.imi.europa.eu/content/future-topics

...which many of us would be interested in.

10) Interesting article on broad vs expert philanthropy

http://blog.givewell.org/2014/10/16/expert-philanthropy-vs-broad-philanthropy/

11) BBC article about challenges faced by the pharma industry

http://www.bbc.co.uk/news/business-29659537

Best,

Mat


-- 
MATTHEW TODD | Associate Professor
School of Chemistry | Faculty of Science

THE UNIVERSITY OF SYDNEY
Rm 519, F11 | The University of Sydney | NSW | 2006
T +61 2 9351 2180  | F +61 2 9351 3329  | M +61 415 274104
E matthew.todd at sydney.edu.au | W
http://sydney.edu.au/science/chemistry/research/todd.html | W
http://opensourcemalaria.org/

CRICOS 00026A
This email plus any attachments to it are confidential. Any unauthorised
use is strictly prohibited. If you receive this email in error, please
delete it and any attachments.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20141114/93ea599e/attachment.html>